GREAT POINT PARTNERS LLC - RENEO PHARMACEUTICALS INC ownership

RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 53 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,887,170
+25.1%
1,167,061
+7.7%
1.62%
+16.4%
Q2 2023$7,106,560
+883.2%
1,083,317
+796.3%
1.39%
+879.6%
Q1 2023$722,767120,8640.14%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,409,220$8,071,0009.37%
Abingworth LLP 2,073,957$6,948,0002.38%
Aisling Capital Management LP 886,075$2,968,0001.97%
NEA Management Company, LLC 4,786,921$16,036,0000.80%
Novo Holdings A/S 3,430,377$11,492,0000.55%
Ikarian Capital, LLC 155,819$521,0000.10%
Rock Springs Capital Management LP 1,143,185$3,830,0000.10%
Ergoteles LLC 37,640$126,0000.00%
MAI Capital Management 63,210$212,0000.00%
RBF Capital, LLC 14,536$49,0000.00%
View complete list of RENEO PHARMACEUTICALS INC shareholders